Phase III Study Adj GEJ & Esoph US EU mono
Research payments
$6,210,041
Through program year 2021, $6,210,041 in research payments was reported against Phase III Study Adj GEJ & Esoph US EU mono, across 166 payments, paid by E.R. Squibb & Sons, L.L.C..
- Paid by
- E.R. Squibb & Sons, L.L.C.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2021 | Research | $805,488 | 46 |
| 2020 | Research | $2,534,618 | 51 |
| 2019 | Research | $2,869,935 | 69 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
9 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- James Cleary Boston, MA Named on 15 payments
- Jaffer Ajani Houston, TX Named on 8 payments
- Usman Shah Allentown, PA Named on 6 payments
- Andrew Ko San Francisco, CA Named on 5 payments
- Vijay Patel Gainesville, FL Named on 5 payments
- Charles Lopez Portland, OR Named on 4 payments
- Tarek Eldawy Pensacola, FL Named on 4 payments
- Daniel Catenacci Chicago, IL Named on 4 payments
- John Salmon Charlotte, NC Named on 3 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.